Clinical Trials : Hemophilia

Active, not recruiting

Nombre del estudio: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
Condición: Hemophilia B
Fecha: 2015-03-04
Intervenciones: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name:

Completed

Nombre del estudio: Study of Biostate® in Children With Hemophilia A
Condición: Hemophilia A
Fecha: 2010-10-01
Intervenciones: Biological: Biostate 1 dose of 50 IU FVIII/kg body weight of Biostate administered intravenously on Day

Completed

Nombre del estudio: Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia
Condición: Hemophilia
Fecha: 2014-02-15
Intervenciones:

Biological: Cellular therapy b

Completed

Nombre del estudio: Hemophilia Inhibitor Genetics Study (HIGS)
Condición: Hemophilia A With Inhibitor
Fecha: 2005-09-09
Intervenciones: Procedure: Blood draw A single blood draw. Other Nam

Active, not recruiting

Nombre del estudio: National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
Condición: Hemophilia A
Fecha: 2015-07-17
Intervenciones: Behavioral: Educational Package Patients will be invited to attend a PK educational session as part of t

Completed

Nombre del estudio: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
Condición: Hemophilia A
Fecha: 2006-07-25
Intervenciones:

Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)

Completed

Nombre del estudio: Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
Condición: Hemophilia A
Fecha: 2005-10-20
Intervenciones: Biological: ReFacto AF

Completed

Nombre del estudio: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
Condición: Hemophilia A
Fecha: 2016-07-26
Intervenciones: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u

Completed

Nombre del estudio: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
Condición: Hemophilia A
Fecha: 2012-03-22
Intervenciones: Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus

Enrolling by invitation

Nombre del estudio: Platelet Function in Patients With Hemophilia A
Condición: Hemophilia A
Fecha: 2014-03-19

Buscar resultados de ensayos clínicos

Hemophilia - 100 Studies Found

Estado	Estudiar
Active, not recruiting	Nombre del estudio: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B Condición: Hemophilia B Fecha: 2015-03-04 Intervenciones: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name:
Completed	Nombre del estudio: Study of Biostate® in Children With Hemophilia A Condición: Hemophilia A Fecha: 2010-10-01 Intervenciones: Biological: Biostate 1 dose of 50 IU FVIII/kg body weight of Biostate administered intravenously on Day
Completed	Nombre del estudio: Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia Condición: Hemophilia Fecha: 2014-02-15 Intervenciones: Biological: Cellular therapy b
Completed	Nombre del estudio: Hemophilia Inhibitor Genetics Study (HIGS) Condición: Hemophilia A With Inhibitor Fecha: 2005-09-09 Intervenciones: Procedure: Blood draw A single blood draw. Other Nam
Active, not recruiting	Nombre del estudio: National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A Condición: Hemophilia A Fecha: 2015-07-17 Intervenciones: Behavioral: Educational Package Patients will be invited to attend a PK educational session as part of t
Completed	Nombre del estudio: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery Condición: Hemophilia A Fecha: 2006-07-25 Intervenciones: Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)
Completed	Nombre del estudio: Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery Condición: Hemophilia A Fecha: 2005-10-20 Intervenciones: Biological: ReFacto AF
Completed	Nombre del estudio: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Condición: Hemophilia A Fecha: 2016-07-26 Intervenciones: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u
Completed	Nombre del estudio: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A Condición: Hemophilia A Fecha: 2012-03-22 Intervenciones: Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus
Enrolling by invitation	Nombre del estudio: Platelet Function in Patients With Hemophilia A Condición: Hemophilia A Fecha: 2014-03-19